Non-alcoholic fatty liver disease: More than just ectopic fat accumulation

Drug Discovery Today: Disease Mechanisms

Volumn 10, Issue 1-2, 2013, Pages

  Barrera, Francisco ^a,b   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CARBOHYDRATE; LEPTIN; LIPID; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCOUPLING PROTEIN 2; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CORONARY ARTERY CALCIFICATION; DIETARY INTAKE; DISEASE COURSE; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIVER CANCER; LIVER FIBROSIS; LIVER PARENCHYMA; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS ISLET TRANSPLANTATION; PREGNANCY; REVIEW;

EID: 84880217848     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2013.06.002     Document Type: Review

References (75)

1. B.A. Swinburn The global obesity pandemic: shaped by global drivers and local environments Lancet 378 2011 804 814
2. C. Boza Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass Obes. Surg. 15 2005 1148 1153
3. M. Arrese Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus Nat. Rev. Endocrinol. 6 2010 660 661
4. P. Angulo Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance Hepatology 51 2010 373 375
5. G. Marchesini Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
6. M. Ekstedt Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
7. L.A. Adams The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J. Hepatol. 42 2005 132 138
8. P. Angulo The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
9. L.A. Adams The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
10. J.C. Cohen Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
11. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
12. N. Ouchi Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
13. H.L. Kammoun GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice J. Clin. Invest. 119 2009 1201 1215
14. K.L. Donnelly Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J. Clin. Invest. 115 2005 1343 1351
15. A. Kosteli Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue J. Clin. Invest. 120 2010 3466 3479
16. C.N. Lumeng Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity Diabetes 56 2007 16 23
17. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
18. C.N. Lumeng Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes Diabetes 57 2008 3239 3246
19. D.Y. Oh Increased macrophage migration into adipose tissue in obese mice Diabetes 61 2012 346 354
20. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J. Clin. Invest. 121 2011 2111 2117
21. K. Imajo Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling Cell Metab. 16 2012 44 54
22. G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view J. Hepatol. 51 2009 212 223
23. K. Yamaguchi Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 45 2007 1366 1374
24. G.C. Farrell NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications Gut Liver 6 2012 149 171
25. S.W. Park Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity Proc. Natl. Acad. Sci. U. S. A. 107 2010 19320 19325
26. N.E. Sunny Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease Cell Metab. 14 2011 804 810
27. S. Wang Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo Metabolism 60 2011 1090 1099
28. S. Satapati Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver J. Lipid Res. 53 2012 1080 1092
29. G. Serviddio Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury Gut 57 2008 957 965
30. P.L. Liew Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease Obes. Surg. 16 2006 1584 1593
31. J. Henao-Mejia Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
32. C.L. Roth Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation Hepatology 55 2012 1103 1111
33. Q. Song, and I.N. Sergeev Calcium and vitamin D in obesity Nutr. Res. Rev. 25 2012 130 141
34. J.B. Schwimmer Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
35. S. Romeo Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat. Genet. 40 2008 1461 1465
36. Y. Rotman The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Hepatology 52 2010 894 903
37. L. Valenti PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease Dig. Liver Dis. 2013 10.1016/j.dld.2012.12. 006 [Epub ahead of print]
38. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
39. M. Kumari Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase Cell Metab. 15 2012 691 702
40. K.F. Petersen Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N. Engl. J. Med. 362 2010 1082 1089
41. E.K. Speliotes Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits PLoS Genet. 7 2011 e1001324
42. N. Chalasani Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease Gastroenterology 139 2010 1567 1576 1576 e1561-1566
43. J. Kozlitina Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance Hepatology 53 2011 467 474
44. L.A. Adams Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease Hepatology 57 2013 590 600
45. A.J. Hooper Genetic determinants of hepatic steatosis in man J. Lipid Res. 52 2011 593 617
46. M. Zeybel Multigenerational epigenetic adaptation of the hepatic wound-healing response Nat. Med. 18 2012 1592
47. A. Mouralidarane Maternal obesity programs offspring non-alcoholic fatty liver disease via innate immune dysfunction in mice Hepatology 2013 10.1002/hep.26248 [Epub ahead of print]
48. J.P. Despres, and I. Lemieux Abdominal obesity and metabolic syndrome Nature 444 2006 881 887
49. E. Fabbrini Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
50. E. Fabbrini Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proc. Natl. Acad. Sci. U. S. A. 106 2009 15430 15435
51. F.R. Jornayvaz, and G.I. Shulman Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance Cell Metab. 15 2012 574 584
52. W.L. Holland Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice J. Clin. Invest. 121 2011 1858 1870
53. A. Kotronen Effect of liver fat on insulin clearance Am. J. Physiol. Endocrinol. Metab. 293 2007 E1709 E1715
54. M. Monetti Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab. 6 2007 69 78
55. A.C. Konner, and J.C. Bruning Selective insulin and leptin resistance in metabolic disorders Cell Metab. 16 2012 144 152
56. G. Targher Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N. Engl. J. Med. 363 2010 1341 1350
57. D. Kim Nonalcoholic fatty liver disease is associated with coronary artery calcification Hepatology 56 2012 605 613
58. J. Liu Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study Atherosclerosis 224 2012 521 525
59. J. Ding Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the multi-ethnic study of atherosclerosis Am. J. Clin. Nutr. 88 2008 645 650
60. G. Targher Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C J. Hepatol. 46 2007 1126 1132
61. L.A. Adams Mortality in nonalcoholic fatty liver disease: clues from the Cremona study Hepatology 54 2011 6 8
62. E.E. Calle Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults N. Engl. J. Med. 348 2003 1625 1638
63. B.Q. Starley Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
64. Y. Chen Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies Eur. J. Cancer 48 2012 2137 2145
65. R. Zoncu mTOR: from growth signal integration to cancer, diabetes and ageing Nat. Rev. Mol. Cell Biol. 12 2011 21 35
66. M. Evert V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis Hepatology 55 2012 1473 1484
67. N.K. Saxena Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma Gastroenterology 139 2010 1762 1773 1773 e1761-1765
68. D. Sharma Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis Hepatology 52 2010 1713 1722
69. V.W. Wong High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis Gut 60 2011 829 836
70. A. Bilici A case-control study of non-alcoholic fatty liver disease in breast cancer Med. Oncol. 24 2007 367 371
71. H. Ashrafian Metabolic surgery and cancer: protective effects of bariatric procedures Cancer 117 2011 1788 1799
72. A.R. Vest Bariatric surgery and cardiovascular outcomes: a systematic review Heart 98 2012 1763 1777
73. L.M. Carlsson Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects N. Engl. J. Med. 367 2012 695 704
74. G. Mingrone Bariatric surgery versus conventional medical therapy for type 2 diabetes N. Engl. J. Med. 366 2012 1577 1585
75. P.R. Schauer Bariatric surgery versus intensive medical therapy in obese patients with diabetes N. Engl. J. Med. 366 2012 1567 1576